Mutation rate and genotype variation of Ebola virus from Mali case sequences

T. Hoenen, D. Safronetz, A. Groseth, K. R. Wollenberg, O. A. Koita, B. Diarra, I. S. Fall, F. C. Haidara, F. Diallo, M. Sanogo, Y. S. Sarro, A. Kone, A. C.G. Togo, A. Traore, M. Kodio, A. Dosseh, K. Rosenke, E. De Wit, F. Feldmann, Hideki EbiharaV. J. Munster, K. C. Zoon, H. Feldmann, S. Sow

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

The occurrence of Ebola virus (EBOV) in West Africa during 2013-2015 is unprecedented. Early reports suggested that in this outbreak EBOV is mutating twice as fast as previously observed, which indicates the potential for changes in transmissibility and virulence and could render current molecular diagnostics and countermeasures ineffective. We have determined additional full-length sequences from two clusters of imported EBOV infections into Mali, and we show that the nucleotide substitution rate (9.6 × 10-4 substitutions per site per year) is consistent with rates observed in Central African outbreaks. In addition, overall variation among all genotypes observed remains low. Thus, our data indicate that EBOV is not undergoing rapid evolution in humans during the current outbreak. This finding has important implications for outbreak response and public health decisions and should alleviate several previously raised concerns.

Original languageEnglish (US)
Pages (from-to)117-119
Number of pages3
JournalScience
Volume348
Issue number6230
DOIs
StatePublished - Apr 3 2015
Externally publishedYes

Fingerprint

Ebolavirus
Mali
Mutation Rate
Disease Outbreaks
Genotype
Ebola Hemorrhagic Fever
Western Africa
Molecular Pathology
Virulence
Nucleotides
Public Health

ASJC Scopus subject areas

  • General

Cite this

Hoenen, T., Safronetz, D., Groseth, A., Wollenberg, K. R., Koita, O. A., Diarra, B., ... Sow, S. (2015). Mutation rate and genotype variation of Ebola virus from Mali case sequences. Science, 348(6230), 117-119. https://doi.org/10.1126/science.aaa5646

Mutation rate and genotype variation of Ebola virus from Mali case sequences. / Hoenen, T.; Safronetz, D.; Groseth, A.; Wollenberg, K. R.; Koita, O. A.; Diarra, B.; Fall, I. S.; Haidara, F. C.; Diallo, F.; Sanogo, M.; Sarro, Y. S.; Kone, A.; Togo, A. C.G.; Traore, A.; Kodio, M.; Dosseh, A.; Rosenke, K.; De Wit, E.; Feldmann, F.; Ebihara, Hideki; Munster, V. J.; Zoon, K. C.; Feldmann, H.; Sow, S.

In: Science, Vol. 348, No. 6230, 03.04.2015, p. 117-119.

Research output: Contribution to journalArticle

Hoenen, T, Safronetz, D, Groseth, A, Wollenberg, KR, Koita, OA, Diarra, B, Fall, IS, Haidara, FC, Diallo, F, Sanogo, M, Sarro, YS, Kone, A, Togo, ACG, Traore, A, Kodio, M, Dosseh, A, Rosenke, K, De Wit, E, Feldmann, F, Ebihara, H, Munster, VJ, Zoon, KC, Feldmann, H & Sow, S 2015, 'Mutation rate and genotype variation of Ebola virus from Mali case sequences', Science, vol. 348, no. 6230, pp. 117-119. https://doi.org/10.1126/science.aaa5646
Hoenen T, Safronetz D, Groseth A, Wollenberg KR, Koita OA, Diarra B et al. Mutation rate and genotype variation of Ebola virus from Mali case sequences. Science. 2015 Apr 3;348(6230):117-119. https://doi.org/10.1126/science.aaa5646
Hoenen, T. ; Safronetz, D. ; Groseth, A. ; Wollenberg, K. R. ; Koita, O. A. ; Diarra, B. ; Fall, I. S. ; Haidara, F. C. ; Diallo, F. ; Sanogo, M. ; Sarro, Y. S. ; Kone, A. ; Togo, A. C.G. ; Traore, A. ; Kodio, M. ; Dosseh, A. ; Rosenke, K. ; De Wit, E. ; Feldmann, F. ; Ebihara, Hideki ; Munster, V. J. ; Zoon, K. C. ; Feldmann, H. ; Sow, S. / Mutation rate and genotype variation of Ebola virus from Mali case sequences. In: Science. 2015 ; Vol. 348, No. 6230. pp. 117-119.
@article{5bec9890fa694bfb9a140c0a152f8c9d,
title = "Mutation rate and genotype variation of Ebola virus from Mali case sequences",
abstract = "The occurrence of Ebola virus (EBOV) in West Africa during 2013-2015 is unprecedented. Early reports suggested that in this outbreak EBOV is mutating twice as fast as previously observed, which indicates the potential for changes in transmissibility and virulence and could render current molecular diagnostics and countermeasures ineffective. We have determined additional full-length sequences from two clusters of imported EBOV infections into Mali, and we show that the nucleotide substitution rate (9.6 × 10-4 substitutions per site per year) is consistent with rates observed in Central African outbreaks. In addition, overall variation among all genotypes observed remains low. Thus, our data indicate that EBOV is not undergoing rapid evolution in humans during the current outbreak. This finding has important implications for outbreak response and public health decisions and should alleviate several previously raised concerns.",
author = "T. Hoenen and D. Safronetz and A. Groseth and Wollenberg, {K. R.} and Koita, {O. A.} and B. Diarra and Fall, {I. S.} and Haidara, {F. C.} and F. Diallo and M. Sanogo and Sarro, {Y. S.} and A. Kone and Togo, {A. C.G.} and A. Traore and M. Kodio and A. Dosseh and K. Rosenke and {De Wit}, E. and F. Feldmann and Hideki Ebihara and Munster, {V. J.} and Zoon, {K. C.} and H. Feldmann and S. Sow",
year = "2015",
month = "4",
day = "3",
doi = "10.1126/science.aaa5646",
language = "English (US)",
volume = "348",
pages = "117--119",
journal = "Science",
issn = "0036-8075",
publisher = "American Association for the Advancement of Science",
number = "6230",

}

TY - JOUR

T1 - Mutation rate and genotype variation of Ebola virus from Mali case sequences

AU - Hoenen, T.

AU - Safronetz, D.

AU - Groseth, A.

AU - Wollenberg, K. R.

AU - Koita, O. A.

AU - Diarra, B.

AU - Fall, I. S.

AU - Haidara, F. C.

AU - Diallo, F.

AU - Sanogo, M.

AU - Sarro, Y. S.

AU - Kone, A.

AU - Togo, A. C.G.

AU - Traore, A.

AU - Kodio, M.

AU - Dosseh, A.

AU - Rosenke, K.

AU - De Wit, E.

AU - Feldmann, F.

AU - Ebihara, Hideki

AU - Munster, V. J.

AU - Zoon, K. C.

AU - Feldmann, H.

AU - Sow, S.

PY - 2015/4/3

Y1 - 2015/4/3

N2 - The occurrence of Ebola virus (EBOV) in West Africa during 2013-2015 is unprecedented. Early reports suggested that in this outbreak EBOV is mutating twice as fast as previously observed, which indicates the potential for changes in transmissibility and virulence and could render current molecular diagnostics and countermeasures ineffective. We have determined additional full-length sequences from two clusters of imported EBOV infections into Mali, and we show that the nucleotide substitution rate (9.6 × 10-4 substitutions per site per year) is consistent with rates observed in Central African outbreaks. In addition, overall variation among all genotypes observed remains low. Thus, our data indicate that EBOV is not undergoing rapid evolution in humans during the current outbreak. This finding has important implications for outbreak response and public health decisions and should alleviate several previously raised concerns.

AB - The occurrence of Ebola virus (EBOV) in West Africa during 2013-2015 is unprecedented. Early reports suggested that in this outbreak EBOV is mutating twice as fast as previously observed, which indicates the potential for changes in transmissibility and virulence and could render current molecular diagnostics and countermeasures ineffective. We have determined additional full-length sequences from two clusters of imported EBOV infections into Mali, and we show that the nucleotide substitution rate (9.6 × 10-4 substitutions per site per year) is consistent with rates observed in Central African outbreaks. In addition, overall variation among all genotypes observed remains low. Thus, our data indicate that EBOV is not undergoing rapid evolution in humans during the current outbreak. This finding has important implications for outbreak response and public health decisions and should alleviate several previously raised concerns.

UR - http://www.scopus.com/inward/record.url?scp=84928773215&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928773215&partnerID=8YFLogxK

U2 - 10.1126/science.aaa5646

DO - 10.1126/science.aaa5646

M3 - Article

C2 - 25814067

AN - SCOPUS:84928773215

VL - 348

SP - 117

EP - 119

JO - Science

JF - Science

SN - 0036-8075

IS - 6230

ER -